COVID-19
World’s first COVID-19 vaccine booster study launches in UK
May 20, 2021COVID-19, UK government, booster vaccine, clinical trial, vaccines
The UK government has announced that thousands of volunteers will receive a booster COVID-19 vaccine in a new clinical trial, …
Oxford University to collaborate with Oracle on COVID variant research
May 17, 2021Sales and Marketing AI, COVID-19, Oxford, variants
In response to emerging variants of COVID-19, Oxford University and Oracle have created a Global Pathogen Analysis System (GPAS), combining …
Delayed Pfizer vaccine dose gives 3.5 times more immunity, study shows
May 14, 2021Medical Communications COVID-19, COVID-19 vaccine, Pfizer vaccine, pfizer-biontech vaccine, pharma, pharma news
The Pfizer-BioNTech COVID-19 vaccine is around three and a half times more effective when dosed 12 weeks apart, a Birmingham …
Pharmafile.com’s weekly COVID-19 news round-up
May 12, 2021Research and Development COVID-19
The past week has seen India’s highest number of COVID-19 deaths, with 4,205 fatalities in a single day. There has …
India report record number of COVID deaths as bodies drift down Ganges
May 12, 2021Research and Development COVID-19, India, Indian COVID crisis, covid 19 news, covid-19 news, pharma, pharma news
India yesterday reported the country’s highest COVID-19 death total for a single day, with 4,205 fatalities officially confirmed.
FDA authorizes use of Pfizer vaccine for children aged 12-15
May 11, 2021Manufacturing and Production COVID-19, FDA, Pfizer, Vaccine
The FDA announced it has expanded the emergency use of the Pfizer-BioNTech vaccine in children aged 12-15 yesterday.It was determined …
EMA begin review of GSK & Vir COVID-19 treatment
May 10, 2021Sales and Marketing COVID-19, EMA, GSK, covid-19 treatment, pharma, pharma news, vir
The EMA has begun a rolling review of GSK and Vir’s sotrovimab treatment for COVID-19, which will continue until there …
Biomarker linked to male hair loss found to determine COVID-19 severity
May 7, 2021Medical Communications COVID-19, hair loss
Findings presented at the European Academy of Dermatology and Venereology (EADV) Spring Symposium suggest that men with genetic characteristics (phenotypes) …
Canada first country to authorise Pfizer vaccine in children aged 12-15
May 6, 2021COVID-19, Canada, Pfizer, Vaccine
Canada has become the first country to authorise the use of Pfizer’s COVID-19 vaccine for children aged between 12 and …
COVID-19: Moderna booster shots appear to increase immunity
May 6, 2021COVID-19, COVID-19 vaccine, Moderna, covid news, pharma, pharma news
Moderna’s mRNA booster jabs for people already vaccinated against COVID-19 have shown positive initial data in a Phase II study …
Pharmafile.com’s weekly COVID-19 news round-up
May 5, 2021Research and Development COVID-19, COVID-19 vaccine, covid 19 news, covid-19 news, pharma, pharma news
The past week has seen more COVID-19 vaccine and treatment news: Moderna will supply up to 500 million jabs to …
UK government to invest £29.3 million on COVID-19 variant testing
May 5, 2021Research and Development COVID-19, UK government, Vaccine, variants
The UK government has announced an investment of £29.3 million, on top of the £19.7 million already pledged, to be …
Moderna to supply up to 500 million COVID-19 vaccines to COVAX
May 4, 2021Manufacturing and Production, Sales and Marketing COVAX, COVID-19, Moderna, Vaccine, WHO
Moderna have announced a supply agreement with Gavi, the Vaccine Alliance, for up to 500 million doses of their COVID-19 …
Pharmafile.com’s top 10 news stories of the week
April 30, 2021Medical Communications COVID-19, covid 19 news, covid-19 news, news roundup, pharma, pharma news
Among our top 10 stories this week: In COVID news, an app has revealed the most common side effects for …
Celltrion’s COVID-19 treatment shows promise against South African variant
April 30, 2021Medical Communications COVID-19, celltrion, covid 19 news, covid-19 news, covid-19 treatment, pharma, pharma news
Celltrion’s regdanvimab treatment for COVID-19 has shown itself to be effective against the South African variant of the virus, according …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
